Ownership
Private
Employees
~20000
Therapeutic Areas
Other
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved

SYNLAB General Information

SYNLAB operates one of the largest clinical laboratory networks in Europe and globally. It conducts approximately 600 million tests annually across more than 30 countries. The company leads in innovation for medical diagnostics with a focus on personalized medicine and evidence-based healthcare. Its research institute IRCCS SDN SYNLAB in Naples exemplifies its commitment to translating science into clinical practice. The group collaborates extensively with universities and research centers to advance diagnostic science

Contact Information

Primary Industry
Molecular Diagnostics
Corporate Office
Munich,
Germany

Drug Pipeline

No pipeline data available

For full access to SYNLAB's pipeline data

Book a demo

Key Partnerships

National Health Service (NHS) UK contract for pathology services, Collaborations with global public health institutions

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

SYNLAB Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view SYNLAB's complete valuation and funding history, request access »

SYNLAB Financial Metrics